{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:10:22Z","timestamp":1791090622304,"version":"4.1.0"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,3,8]],"date-time":"2011-03-08T00:00:00Z","timestamp":1299542400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1007\/s11060-011-0559-8","type":"journal-article","created":{"date-parts":[[2011,3,8]],"date-time":"2011-03-08T11:06:15Z","timestamp":1299582375000},"page":"411-422","source":"Crossref","is-referenced-by-count":39,"title":["The biological basis for modern treatment of chordoma"],"prefix":"10.1007","volume":"104","author":[{"given":"Roberto Jose","family":"Diaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Cusimano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,8]]},"reference":[{"key":"559_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1008947301735","volume":"12","author":"ML McMaster","year":"2001","unstructured":"McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM (2001) Chordoma: incidence and survival patterns in the United States, 1973\u20131995. Cancer Causes Control 12:1\u201311","journal-title":"Cancer Causes Control"},{"key":"559_CR2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/1097-0142(19950101)75:1+<203::AID-CNCR2820751308>3.0.CO;2-V","volume":"75","author":"HD Dorfman","year":"1995","unstructured":"Dorfman HD, Czerniak B (1995) Bone cancers. Cancer 75:203\u2013210","journal-title":"Cancer"},{"key":"559_CR3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/17453678108991758","volume":"52","author":"B Eriksson","year":"1981","unstructured":"Eriksson B, Gunterberg B, Kindblom LG (1981) Chordoma. A clinicopathologic and prognostic study of a Swedish national series. Acta Orthop Scand 52:49\u201358","journal-title":"Acta Orthop Scand"},{"key":"559_CR4","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/1097-0142(196711)20:11<1841::AID-CNCR2820201107>3.0.CO;2-2","volume":"20","author":"NL Higinbotham","year":"1967","unstructured":"Higinbotham NL, Phillips RF, Farr HW, Hustu HO (1967) Chordoma. Thirty-five-year study at Memorial Hospital. Cancer 20:1841\u20131850","journal-title":"Cancer"},{"key":"559_CR5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3171\/jns.2001.95.2.0175","volume":"95","author":"HA Crockard","year":"2001","unstructured":"Crockard HA, Steel T, Plowman N, Singh A, Crossman J, Revesz T, Holton JL, Cheeseman A (2001) A multidisciplinary team approach to skull base chordomas. J Neurosurg 95:175\u2013183. doi: 10.3171\/jns.2001.95.2.0175","journal-title":"J Neurosurg"},{"key":"559_CR6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10143-007-0099-z","volume":"31","author":"YH Cho","year":"2008","unstructured":"Cho YH, Kim JH, Khang SK, Lee JK, Kim CJ (2008) Chordomas and chondrosarcomas of the skull base: comparative analysis of clinical results in 30 patients. Neurosurg Rev 31:35\u201343. doi: 10.1007\/s10143-007-0099-z (discussion 43)","journal-title":"Neurosurg Rev"},{"key":"559_CR7","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3171\/jns.2001.95.6.0933","volume":"95","author":"B Colli","year":"2001","unstructured":"Colli B, Al-Mefty O (2001) Chordomas of the craniocervical junction: follow-up review and prognostic factors. J Neurosurg 95:933\u2013943. doi: 10.3171\/jns.2001.95.6.0933","journal-title":"J Neurosurg"},{"key":"559_CR8","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3171\/jns.1993.78.5.0741","volume":"78","author":"PA Forsyth","year":"1993","unstructured":"Forsyth PA, Cascino TL, Shaw EG, Scheithauer BW, O\u2019Fallon JR, Dozier JC, Piepgras DG (1993) Intracranial chordomas: a clinicopathological and prognostic study of 51 cases. J Neurosurg 78:741\u2013747. doi: 10.3171\/jns.1993.78.5.0741","journal-title":"J Neurosurg"},{"key":"559_CR9","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3171\/jns.2003.98.4.0812","volume":"98","author":"R Pallini","year":"2003","unstructured":"Pallini R, Maira G, Pierconti F, Falchetti ML, Alvino E, Cimino-Reale G, Fernandez E, D\u2019Ambrosio E, Larocca LM (2003) Chordoma of the skull base: predictors of tumor recurrence. J Neurosurg 98:812\u2013822. doi: 10.3171\/jns.2003.98.4.0812","journal-title":"J Neurosurg"},{"key":"559_CR10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00000478-198303000-00006","volume":"7","author":"R Volpe","year":"1983","unstructured":"Volpe R, Mazabraud A (1983) A clinicopathologic review of 25 cases of chordoma (a pleomorphic and metastasizing neoplasm). Am J Surg Pathol 7:161\u2013170","journal-title":"Am J Surg Pathol"},{"key":"559_CR11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1245\/ASO.2003.06.002","volume":"10","author":"D Baratti","year":"2003","unstructured":"Baratti D, Gronchi A, Pennacchioli E, Lozza L, Colecchia M, Fiore M, Santinami M (2003) Chordoma: natural history and results in 28 patients treated at a single institution. Ann Surg Oncol 10:291\u2013296","journal-title":"Ann Surg Oncol"},{"key":"559_CR12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/BRS.0b013e3181b44387","volume":"35","author":"MU Jawad","year":"2010","unstructured":"Jawad MU, Scully SP (2010) Surgery significantly improves survival in patients with chordoma. Spine (Phila Pa 1976) 35:117\u2013123. doi: 10.1097\/BRS.0b013e3181b44387","journal-title":"Spine (Phila Pa 1976)"},{"key":"559_CR13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00000421-199008000-00013","volume":"13","author":"M Austin-Seymour","year":"1990","unstructured":"Austin-Seymour M, Munzenrider J, Linggood R, Goitein M, Verhey L, Urie M, Gentry R, Birnbaum S, Ruotolo D, Crowell C et al (1990) Fractionated proton radiation therapy of cranial and intracranial tumors. Am J Clin Oncol 13:327\u2013330","journal-title":"Am J Clin Oncol"},{"key":"559_CR14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3171\/jns.1999.91.3.0432","volume":"91","author":"EB Hug","year":"1999","unstructured":"Hug EB, Loredo LN, Slater JD, DeVries A, Grove RI, Schaefer RA, Rosenberg AE, Slater JM (1999) Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg 91:432\u2013439. doi: 10.3171\/jns.1999.91.3.0432","journal-title":"J Neurosurg"},{"key":"559_CR15","doi-asserted-by":"crossref","unstructured":"Ito E, Saito K, Okada T, Nagatani T, Nagasaka T (2009) Long-term control of clival chordoma with initial aggressive surgical resection and gamma knife radiosurgery for recurrence. Acta Neurochir (Wien). doi: 10.1007\/s00701-009-0535-7","DOI":"10.1007\/s00701-009-0535-7"},{"key":"559_CR16","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3171\/JNS-07\/10\/0752","volume":"107","author":"T Hasegawa","year":"2007","unstructured":"Hasegawa T, Ishii D, Kida Y, Yoshimoto M, Koike J, Iizuka H (2007) Gamma Knife surgery for skull base chordomas and chondrosarcomas. J Neurosurg 107:752\u2013757. doi: 10.3171\/JNS-07\/10\/0752","journal-title":"J Neurosurg"},{"key":"559_CR17","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3171\/JNS-07\/10\/0758","volume":"107","author":"JJ Martin","year":"2007","unstructured":"Martin JJ, Niranjan A, Kondziolka D, Flickinger JC, Lozanne KA, Lunsford LD (2007) Radiosurgery for chordomas and chondrosarcomas of the skull base. J Neurosurg 107:758\u2013764. doi: 10.3171\/JNS-07\/10\/0758","journal-title":"J Neurosurg"},{"key":"559_CR18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/1097-0142(19930201)71:3<735::AID-CNCR2820710314>3.0.CO;2-8","volume":"71","author":"J Bjornsson","year":"1993","unstructured":"Bjornsson J, Wold LE, Ebersold MJ, Laws ER (1993) Chordoma of the mobile spine. a clinicopathologic analysis of 40 patients. Cancer 71:735\u2013740","journal-title":"Cancer"},{"key":"559_CR19","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s002689900110","volume":"20","author":"RY Chandawarkar","year":"1996","unstructured":"Chandawarkar RY (1996) Sacrococcygeal chordoma: review of 50 consecutive patients. World J Surg 20:717\u2013719","journal-title":"World J Surg"},{"key":"559_CR20","doi-asserted-by":"crossref","unstructured":"Choi D, Melcher R, Harms J, Crockard A Outcome of 132 operations in 97 patients with chordomas of the craniocervical junction and upper cervical spine. Neurosurgery 66: 59\u201365, discussion 65. doi: 10.1227\/01.NEU.0000362000.35742.3D","DOI":"10.1227\/01.NEU.0000362000.35742.3D"},{"key":"559_CR21","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2214\/ajr.172.5.10227531","volume":"172","author":"FJ Wippold 2nd","year":"1999","unstructured":"Wippold FJ 2nd, Koeller KK, Smirniotopoulos JG (1999) Clinical and imaging features of cervical chordoma. Am J Roentgenol 172:1423\u20131426","journal-title":"Am J Roentgenol"},{"key":"559_CR22","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.3171\/foc.2001.10.3.2","volume":"10","author":"BO Colli","year":"2001","unstructured":"Colli BO, Al-Mefty O (2001) Chordomas of the skull base: follow-up review and prognostic factors. Neurosurg Focus 10:E1. doi: 10.3171\/foc.2001.10.3.2","journal-title":"Neurosurg Focus"},{"key":"559_CR23","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/0046-8177(95)90301-1","volume":"26","author":"S Suster","year":"1995","unstructured":"Suster S, Moran CA (1995) Chordomas of the mediastinum: clinicopathologic, immunohistochemical, and ultrastructural study of six cases presenting as posterior mediastinal masses. Hum Pathol 26:1354\u20131362","journal-title":"Hum Pathol"},{"key":"559_CR24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0167-8140(96)91805-8","volume":"41","author":"C Catton","year":"1996","unstructured":"Catton C, O\u2019Sullivan B, Bell R, Laperriere N, Cummings B, Fornasier V, Wunder J (1996) Chordoma: long-term follow-up after radical photon irradiation. Radiother Oncol 41:67\u201372","journal-title":"Radiother Oncol"},{"key":"559_CR25","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/ajcp\/72.5.765","volume":"72","author":"PW Chambers","year":"1979","unstructured":"Chambers PW, Schwinn CP (1979) Chordoma. A clinicopathologic study of metastasis. Am J Clin Pathol 72:765\u2013776","journal-title":"Am J Clin Pathol"},{"key":"559_CR26","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00000372-199512000-00014","volume":"17","author":"AM Cesinaro","year":"1995","unstructured":"Cesinaro AM, Maiorana A, Annessi G, Collina G (1995) Cutaneous metastasis of chordoma. Am J Dermatopathol 17:603\u2013605","journal-title":"Am J Dermatopathol"},{"key":"559_CR27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2214\/ajr.174.2.1740417","volume":"174","author":"J Llauger","year":"2000","unstructured":"Llauger J, Palmer J, Amores S, Bague S, Camins A (2000) Primary tumors of the sacrum: diagnostic imaging. Am J Roentgenol 174:417\u2013424","journal-title":"Am J Roentgenol"},{"key":"559_CR28","first-page":"1627","volume":"13","author":"SP Meyers","year":"1992","unstructured":"Meyers SP, Hirsch WL Jr, Curtin HD, Barnes L, Sekhar LN, Sen C (1992) Chordomas of the skull base: MR features. Am J Neuroradiol 13:1627\u20131636","journal-title":"Am J Neuroradiol"},{"key":"559_CR29","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1002\/cncr.23073","volume":"110","author":"K Almefty","year":"2007","unstructured":"Almefty K, Pravdenkova S, Colli BO, Al-Mefty O, Gokden M (2007) Chordoma and chondrosarcoma: similar, but quite different, skull base tumors. Cancer 110:2457\u20132467. doi: 10.1002\/cncr.23073","journal-title":"Cancer"},{"key":"559_CR30","first-page":"627","volume":"27","author":"MA Rossleigh","year":"1986","unstructured":"Rossleigh MA, Smith J, Yeh SD (1986) Scintigraphic features of primary sacral tumors. J Nucl Med 27:627\u2013630","journal-title":"J Nucl Med"},{"key":"559_CR31","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1097\/RLU.0b013e31818c4e88","volume":"33","author":"SA Park","year":"2008","unstructured":"Park SA, Kim HS (2008) F-18 FDG PET\/CT evaluation of sacrococcygeal chordoma. Clin Nucl Med 33:906\u2013908. doi: 10.1097\/RLU.0b013e31818c4e88","journal-title":"Clin Nucl Med"},{"key":"559_CR32","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00256-004-0815-5","volume":"33","author":"H Zhang","year":"2004","unstructured":"Zhang H, Yoshikawa K, Tamura K, Sagou K, Tian M, Suhara T, Kandatsu S, Suzuki K, Tanada S, Tsujii H (2004) Carbon-11-methionine positron emission tomography imaging of chordoma. Skeletal Radiol 33:524\u2013530. doi: 10.1007\/s00256-004-0815-5","journal-title":"Skeletal Radiol"},{"key":"559_CR33","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/1097-0142(19941015)74:8<2261::AID-CNCR2820740809>3.0.CO;2-0","volume":"74","author":"JX O\u2019Connell","year":"1994","unstructured":"O\u2019Connell JX, Renard LG, Liebsch NJ, Efird JT, Munzenrider JE, Rosenberg AE (1994) Base of skull chordoma. A correlative study of histologic and clinical features of 62 cases. Cancer 74:2261\u20132267","journal-title":"Cancer"},{"key":"559_CR34","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/cncr.11756","volume":"98","author":"T Naka","year":"2003","unstructured":"Naka T, Boltze C, Samii A, Herold C, Ostertag H, Iwamoto Y, Oda Y, Tsuneyoshi M, Kuester D, Roessner A (2003) Skull base and nonskull base chordomas: clinicopathologic and immunohistochemical study with special reference to nuclear pleomorphism and proliferative ability. Cancer 98:1934\u20131941. doi: 10.1002\/cncr.11756","journal-title":"Cancer"},{"key":"559_CR35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/PAI.0b013e3181866a13","volume":"17","author":"HY Cho","year":"2009","unstructured":"Cho HY, Lee M, Takei H, Dancer J, Ro JY, Zhai QJ (2009) Immunohistochemical comparison of chordoma with chondrosarcoma, myxopapillary ependymoma, and chordoid meningioma. Appl Immunohistochem Mol Morphol 17:131\u2013138. doi: 10.1097\/PAI.0b013e3181866a13","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"559_CR36","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/PAS.0b013e31815b693a","volume":"32","author":"R Tirabosco","year":"2008","unstructured":"Tirabosco R, Mangham DC, Rosenberg AE, Vujovic S, Bousdras K, Pizzolitto S, De Maglio G, den Bakker MA, Di Francesco L, Kalil RK, Athanasou NA, O\u2019Donnell P, McCarthy EF, Flanagan AM (2008) Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor\/myoepithelioma\/parachordoma in soft tissue. Am J Surg Pathol 32:572\u2013580. doi: 10.1097\/PAS.0b013e31815b693a","journal-title":"Am J Surg Pathol"},{"key":"559_CR37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/path.1711710404","volume":"171","author":"JR Salisbury","year":"1993","unstructured":"Salisbury JR (1993) The pathology of the human notochord. J Pathol 171:253\u2013255. doi: 10.1002\/path.1711710404","journal-title":"J Pathol"},{"key":"559_CR38","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/gb-2005-6-9-r76","volume":"6","author":"SR Henderson","year":"2005","unstructured":"Henderson SR, Guiliano D, Presneau N, McLean S, Frow R, Vujovic S, Anderson J, Sebire N, Whelan J, Athanasou N, Flanagan AM, Boshoff C (2005) A molecular map of mesenchymal tumors. Genome Biol 6:R76. doi: 10.1186\/gb-2005-6-9-r76","journal-title":"Genome Biol"},{"key":"559_CR39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/path.1969","volume":"209","author":"S Vujovic","year":"2006","unstructured":"Vujovic S, Henderson S, Presneau N, Odell E, Jacques TS, Tirabosco R, Boshoff C, Flanagan AM (2006) Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol 209:157\u2013165. doi: 10.1002\/path.1969","journal-title":"J Pathol"},{"key":"559_CR40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/dvdy.10480","volume":"229","author":"C Showell","year":"2004","unstructured":"Showell C, Binder O, Conlon FL (2004) T-box genes in early embryogenesis. Dev Dyn 229:201\u2013218. doi: 10.1002\/dvdy.10480","journal-title":"Dev Dyn"},{"key":"559_CR41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/path.1987","volume":"209","author":"S Romeo","year":"2006","unstructured":"Romeo S, Hogendoorn PC (2006) Brachyury and chordoma: the chondroid-chordoid dilemma resolved? J Pathol 209:143\u2013146. doi: 10.1002\/path.1987","journal-title":"J Pathol"},{"key":"559_CR42","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1097\/BRS.0b013e318133fbb5","volume":"32","author":"JB Park","year":"2007","unstructured":"Park JB, Lee CK, Koh JS, Lee JK, Park EY, Riew KD (2007) Overexpressions of nerve growth factor and its tropomyosin-related kinase A receptor on chordoma cells. Spine (Phila Pa 1976) 32:1969\u20131973. doi: 10.1097\/BRS.0b013e318133fbb5","journal-title":"Spine (Phila Pa 1976)"},{"key":"559_CR43","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00256-007-0435-y","volume":"37","author":"T Yamaguchi","year":"2008","unstructured":"Yamaguchi T, Iwata J, Sugihara S, McCarthy EF Jr, Karita M, Murakami H, Kawahara N, Tsuchiya H, Tomita K (2008) Distinguishing benign notochordal cell tumors from vertebral chordoma. Skeletal Radiol 37:291\u2013299. doi: 10.1007\/s00256-007-0435-y","journal-title":"Skeletal Radiol"},{"key":"559_CR44","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2559.2004.01877.x","volume":"44","author":"T Yamaguchi","year":"2004","unstructured":"Yamaguchi T, Suzuki S, Ishiiwa H, Ueda Y (2004) Intraosseous benign notochordal cell tumours: overlooked precursors of classic chordomas? Histopathology 44:597\u2013602. doi: 10.1111\/j.1365-2559.2004.01877.x","journal-title":"Histopathology"},{"key":"559_CR45","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1097\/PAS.0b013e31805c9967","volume":"31","author":"V Deshpande","year":"2007","unstructured":"Deshpande V, Nielsen GP, Rosenthal DI, Rosenberg AE (2007) Intraosseous benign notochord cell tumors (BNCT): further evidence supporting a relationship to chordoma. Am J Surg Pathol 31:1573\u20131577. doi: 10.1097\/PAS.0b013e31805c9967","journal-title":"Am J Surg Pathol"},{"key":"559_CR46","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1002\/dvdy.21805","volume":"237","author":"KS Choi","year":"2008","unstructured":"Choi KS, Cohn MJ, Harfe BD (2008) Identification of nucleus pulposus precursor cells and notochordal remnants in the mouse: implications for disk degeneration and chordoma formation. Dev Dyn 237:3953\u20133958. doi: 10.1002\/dvdy.21805","journal-title":"Dev Dyn"},{"key":"559_CR47","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.4161\/cbt.4.10.2184","volume":"4","author":"Y Katoh","year":"2005","unstructured":"Katoh Y, Katoh M (2005) Hedgehog signaling pathway and gastric cancer. Cancer Biol Ther 4:1050\u20131054","journal-title":"Cancer Biol Ther"},{"key":"559_CR48","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s12094-007-0080-x","volume":"9","author":"LM Anton Aparicio","year":"2007","unstructured":"Anton Aparicio LM, Garcia Campelo R, Cassinello Espinosa J, Valladares Ayerbes M, Reboredo Lopez M, Diaz Prado S, Aparicio Gallego G (2007) Prostate cancer and Hedgehog signalling pathway. Clin Transl Oncol 9:420\u2013428","journal-title":"Clin Transl Oncol"},{"key":"559_CR49","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1089\/107632703768247368","volume":"9","author":"CJ Hunter","year":"2003","unstructured":"Hunter CJ, Matyas JR, Duncan NA (2003) The notochordal cell in the nucleus pulposus: a review in the context of tissue engineering. Tissue Eng 9:667\u2013677. doi: 10.1089\/107632703768247368","journal-title":"Tissue Eng"},{"key":"559_CR50","first-page":"753","volume":"51","author":"ML Deniz","year":"2002","unstructured":"Deniz ML, Kilic T, Almaata I, Kurtkaya O, Sav A, Pamir MN (2002) Expression of growth factors and structural proteins in chordomas: basic fibroblast growth factor, transforming growth factor alpha, and fibronectin are correlated with recurrence. Neurosurgery 51:753\u2013760, discussion 760","journal-title":"Neurosurgery"},{"key":"559_CR51","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.surneu.2006.11.046","volume":"68","author":"F Bayrakli","year":"2007","unstructured":"Bayrakli F, Guney I, Kilic T, Ozek M, Pamir MN (2007) New candidate chromosomal regions for chordoma development. Surg Neurol 68:425\u2013430. doi: 10.1016\/j.surneu.2006.11.046 discussion 430","journal-title":"Surg Neurol"},{"key":"559_CR52","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.clinthera.2006.11.015","volume":"28","author":"T Shih","year":"2006","unstructured":"Shih T, Lindley C (2006) Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies. Clin Ther 28:1779\u20131802. doi: 10.1016\/j.clinthera.2006.11.015","journal-title":"Clin Ther"},{"key":"559_CR53","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/sj.bjc.6604130","volume":"98","author":"KH Hallor","year":"2008","unstructured":"Hallor KH, Staaf J, Jonsson G, Heidenblad M, Vult von Steyern F, Bauer HC, Ijszenga M, Hogendoorn PC, Mandahl N, Szuhai K, Mertens F (2008) Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisation. Br J Cancer 98:434\u2013442. doi: 10.1038\/sj.bjc.6604130","journal-title":"Br J Cancer"},{"key":"559_CR54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cancergencyto.2004.11.016","volume":"160","author":"P Brandal","year":"2005","unstructured":"Brandal P, Bjerkehagen B, Danielsen H, Heim S (2005) Chromosome 7 abnormalities are common in chordomas. Cancer Genet Cytogenet 160:15\u201321. doi: 10.1016\/j.cancergencyto.2004.11.016","journal-title":"Cancer Genet Cytogenet"},{"key":"559_CR55","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3171\/2008.9.JNS08285","volume":"110","author":"KK Almefty","year":"2009","unstructured":"Almefty KK, Pravdenkova S, Sawyer J, Al-Mefty O (2009) Impact of cytogenetic abnormalities on the management of skull base chordomas. J Neurosurg 110:715\u2013724. doi: 10.3171\/2008.9.JNS08285","journal-title":"J Neurosurg"},{"key":"559_CR56","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/00007632-200202150-00010","volume":"27","author":"S Berven","year":"2002","unstructured":"Berven S, Zurakowski D, Mankin HJ, Gebhardt MC, Springfield DS, Hornicek FJ (2002) Clinical outcome in chordoma: utility of flow cytometry in DNA determination. Spine (Phila Pa 1976) 27:374\u2013379","journal-title":"Spine (Phila Pa 1976)"},{"key":"559_CR57","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/ng.454","volume":"41","author":"XR Yang","year":"2009","unstructured":"Yang XR, Ng D, Alcorta DA, Liebsch NJ, Sheridan E, Li S, Goldstein AM, Parry DM, Kelley MJ (2009) T (brachyury) gene duplication confers major susceptibility to familial chordoma. Nat Genet 41:1176\u20131178. doi: 10.1038\/ng.454","journal-title":"Nat Genet"},{"key":"559_CR58","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/modpathol.2009.63","volume":"22","author":"AA Shalaby","year":"2009","unstructured":"Shalaby AA, Presneau N, Idowu BD, Thompson L, Briggs TR, Tirabosco R, Diss TC, Flanagan AM (2009) Analysis of the fibroblastic growth factor receptor-RAS\/RAF\/MEK\/ERK-ETS2\/brachyury signalling pathway in chordomas. Mod Pathol 22:996\u20131005. doi: 10.1038\/modpathol.2009.63","journal-title":"Mod Pathol"},{"key":"559_CR59","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cancergencyto.2006.06.007","volume":"171","author":"L Klingler","year":"2006","unstructured":"Klingler L, Trammell R, Allan DG, Butler MG, Schwartz HS (2006) Clonality studies in sacral chordoma. Cancer Genet Cytogenet 171:68\u201371. doi: 10.1016\/j.cancergencyto.2006.06.007","journal-title":"Cancer Genet Cytogenet"},{"key":"559_CR60","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1215\/15228517-2007-048","volume":"10","author":"M Longoni","year":"2008","unstructured":"Longoni M, Orzan F, Stroppi M, Boari N, Mortini P, Riva P (2008) Evaluation of 1p36 markers and clinical outcome in a skull base chordoma study. Neuro Oncol 10:52\u201360. doi: 10.1215\/15228517-2007-048","journal-title":"Neuro Oncol"},{"key":"559_CR61","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ijc.11421","volume":"107","author":"P Riva","year":"2003","unstructured":"Riva P, Crosti F, Orzan F, Dalpra L, Mortini P, Parafioriti A, Pollo B, Fuhrman Conti AM, Miozzo M, Larizza L (2003) Mapping of candidate region for chordoma development to 1p36.13 by LOH analysis. Int J Cancer 107:493\u2013497. doi: 10.1002\/ijc.11421","journal-title":"Int J Cancer"},{"key":"559_CR62","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/gcc.1184","volume":"32","author":"S Scheil","year":"2001","unstructured":"Scheil S, Bruderlein S, Liehr T, Starke H, Herms J, Schulte M, Moller P (2001) Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1. Genes Chromosomes Cancer 32:203\u2013211. doi: 10.1002\/gcc.1184","journal-title":"Genes Chromosomes Cancer"},{"key":"559_CR63","doi-asserted-by":"crossref","unstructured":"Sommer J, Itani DM, Homlar KC, Keedy VL, Halpern JL, Holt GE, Schwartz HS, Coffin CM, Kelley MJ, Cates JM Methylthioadenosine phosphorylase and activated insulin-like growth factor-1 receptor\/insulin receptor: potential therapeutic targets in chordoma. J Pathol 220:608\u2013617. doi: 10.1002\/path.2679","DOI":"10.1002\/path.2679"},{"key":"559_CR64","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1038\/sj.onc.1202737","volume":"18","author":"KD Robertson","year":"1999","unstructured":"Robertson KD, Jones PA (1999) Tissue-specific alternative splicing in the human INK4a\/ARF cell cycle regulatory locus. Oncogene 18:3810\u20133820. doi: 10.1038\/sj.onc.1202737","journal-title":"Oncogene"},{"key":"559_CR65","doi-asserted-by":"crossref","first-page":"e5735","DOI":"10.1371\/journal.pone.0005735","volume":"4","author":"M Lubin","year":"2009","unstructured":"Lubin M, Lubin A (2009) Selective killing of tumors deficient in methylthioadenosine phosphorylase: a novel strategy. PLoS One 4:e5735. doi: 10.1371\/journal.pone.0005735","journal-title":"PLoS One"},{"key":"559_CR66","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1469-1809.1991.tb00415.x","volume":"55","author":"B Laguda","year":"1991","unstructured":"Laguda B, Selden C, Jones M, Hodgson H, Spurr NK (1991) Assignment of the hepatocyte growth factor (HGF) to chromosome 7q22-qter. Ann Hum Genet 55:213\u2013216","journal-title":"Ann Hum Genet"},{"key":"559_CR67","doi-asserted-by":"crossref","unstructured":"Liu X, Newton RC, Scherle PA (2009) Developing c-MET pathway inhibitors for cancer therapy: progress and challenges. Trends Mol Med. doi: 10.1016\/j.molmed.2009.11.005","DOI":"10.1016\/j.molmed.2009.11.005"},{"key":"559_CR68","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00262-008-0557-7","volume":"58","author":"JH Schwab","year":"2009","unstructured":"Schwab JH, Boland PJ, Agaram NP, Socci ND, Guo T, O\u2019Toole GC, Wang X, Ostroumov E, Hunter CJ, Block JA, Doty S, Ferrone S, Healey JH, Antonescu CR (2009) Chordoma and chondrosarcoma gene profile: implications for immunotherapy. Cancer Immunol Immunother 58:339\u2013349. doi: 10.1007\/s00262-008-0557-7","journal-title":"Cancer Immunol Immunother"},{"key":"559_CR69","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.humpath.2007.06.005","volume":"39","author":"T Naka","year":"2008","unstructured":"Naka T, Kuester D, Boltze C, Schulz TO, Samii A, Herold C, Ostertag H, Roessner A (2008) Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma. Hum Pathol 39:217\u2013223. doi: 10.1016\/j.humpath.2007.06.005","journal-title":"Hum Pathol"},{"key":"559_CR70","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrc1821","volume":"6","author":"CM Overall","year":"2006","unstructured":"Overall CM, Kleifeld O (2006) Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 6:227\u2013239. doi: 10.1038\/nrc1821","journal-title":"Nat Rev Cancer"},{"key":"559_CR71","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1749-6632.1999.tb07702.x","volume":"878","author":"O Teronen","year":"1999","unstructured":"Teronen O, Heikkila P, Konttinen YT, Laitinen M, Salo T, Hanemaaijer R, Teronen A, Maisi P, Sorsa T (1999) MMP inhibition and downregulation by bisphosphonates. Ann N Y Acad Sci 878:453\u2013465","journal-title":"Ann N Y Acad Sci"},{"key":"559_CR72","first-page":"415","volume":"54","author":"A Mittelman","year":"1994","unstructured":"Mittelman A, Chen ZJ, Liu CC, Hirai S, Ferrone S (1994) Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2\u201323. Cancer Res 54:415\u2013421","journal-title":"Cancer Res"},{"key":"559_CR73","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1158\/1078-0432.CCR-06-1584","volume":"12","author":"E Tamborini","year":"2006","unstructured":"Tamborini E, Miselli F, Negri T, Lagonigro MS, Staurengo S, Dagrada GP, Stacchiotti S, Pastore E, Gronchi A, Perrone F, Carbone A, Pierotti MA, Casali PG, Pilotti S (2006) Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas. Clin Cancer Res 12:6920\u20136928. doi: 10.1158\/1078-0432.CCR-06-1584","journal-title":"Clin Cancer Res"},{"key":"559_CR74","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2990.2007.00873.x","volume":"34","author":"JH Fasig","year":"2008","unstructured":"Fasig JH, Dupont WD, LaFleur BJ, Olson SJ, Cates JM (2008) Immunohistochemical analysis of receptor tyrosine kinase signal transduction activity in chordoma. Neuropathol Appl Neurobiol 34:95\u2013104. doi: 10.1111\/j.1365-2990.2007.00873.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"559_CR75","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/archotol.131.8.707","volume":"131","author":"PM Weinberger","year":"2005","unstructured":"Weinberger PM, Yu Z, Kowalski D, Joe J, Manger P, Psyrri A, Sasaki CT (2005) Differential expression of epidermal growth factor receptor, c-Met, and HER2\/neu in chordoma compared with 17 other malignancies. Arch Otolaryngol Head Neck Surg 131:707\u2013711. doi: 10.1001\/archotol.131.8.707","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"559_CR76","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/cncr.23141","volume":"112","author":"T Naka","year":"2008","unstructured":"Naka T, Kuester D, Boltze C, Scheil-Bertram S, Samii A, Herold C, Ostertag H, Krueger S, Roessner A (2008) Expression of hepatocyte growth factor and c-MET in skull base chordoma. Cancer 112:104\u2013110. doi: 10.1002\/cncr.23141","journal-title":"Cancer"},{"key":"559_CR77","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/modpathol.2009.104","volume":"22","author":"Y Dobashi","year":"2009","unstructured":"Dobashi Y, Suzuki S, Sato E, Hamada Y, Yanagawa T, Ooi A (2009) EGFR-dependent and independent activation of Akt\/mTOR cascade in bone and soft tissue tumors. Mod Pathol 22:1328\u20131340. doi: 10.1038\/modpathol.2009.104","journal-title":"Mod Pathol"},{"key":"559_CR78","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/sj.bjc.6605019","volume":"100","author":"N Presneau","year":"2009","unstructured":"Presneau N, Shalaby A, Idowu B, Gikas P, Cannon SR, Gout I, Diss T, Tirabosco R, Flanagan AM (2009) Potential therapeutic targets for chordoma: PI3\u00a0K\/AKT\/TSC1\/TSC2\/mTOR pathway. Br J Cancer 100:1406\u20131414. doi: 10.1038\/sj.bjc.6605019","journal-title":"Br J Cancer"},{"key":"559_CR79","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/CAD.0b013e328330c7f0","volume":"20","author":"N Singhal","year":"2009","unstructured":"Singhal N, Kotasek D, Parnis FX (2009) Response to erlotinib in a patient with treatment refractory chordoma. Anticancer Drugs 20:953\u2013955. doi: 10.1097\/CAD.0b013e328330c7f0","journal-title":"Anticancer Drugs"},{"key":"559_CR80","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1159\/000096283","volume":"29","author":"H Hof","year":"2006","unstructured":"Hof H, Welzel T, Debus J (2006) Effectiveness of cetuximab\/gefitinib in the therapy of a sacral chordoma. Onkologie 29:572\u2013574. doi: 10.1159\/000096283","journal-title":"Onkologie"},{"key":"559_CR81","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/02841860802266672","volume":"48","author":"O Linden","year":"2009","unstructured":"Linden O, Stenberg L, Kjellen E (2009) Regression of cervical spinal cord compression in a patient with chordoma following treatment with cetuximab and gefitinib. Acta Oncol 48:158\u2013159. doi: 10.1080\/02841860802266672","journal-title":"Acta Oncol"},{"key":"559_CR82","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/01.cco.0000143964.74936.d1","volume":"16","author":"EK Rowinsky","year":"2004","unstructured":"Rowinsky EK (2004) Targeting the molecular target of rapamycin (mTOR). Curr Opin Oncol 16:564\u2013575","journal-title":"Curr Opin Oncol"},{"key":"559_CR83","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1586\/14737140.7.8.1145","volume":"7","author":"AR MacKenzie","year":"2007","unstructured":"MacKenzie AR, von Mehren M (2007) Mechanisms of mammalian target of rapamycin inhibition in sarcoma: present and future. Expert Rev Anticancer Ther 7:1145\u20131154. doi: 10.1586\/14737140.7.8.1145","journal-title":"Expert Rev Anticancer Ther"},{"key":"559_CR84","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/gcc.20052","volume":"41","author":"L Lee-Jones","year":"2004","unstructured":"Lee-Jones L, Aligianis I, Davies PA, Puga A, Farndon PA, Stemmer-Rachamimov A, Ramesh V, Sampson JR (2004) Sacrococcygeal chordomas in patients with tuberous sclerosis complex show somatic loss of TSC1 or TSC2. Genes Chromosomes Cancer 41:80\u201385. doi: 10.1002\/gcc.20052","journal-title":"Genes Chromosomes Cancer"},{"key":"559_CR85","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s004310000645","volume":"160","author":"J Borgel","year":"2001","unstructured":"Borgel J, Olschewski H, Reuter T, Miterski B, Epplen JT (2001) Does the tuberous sclerosis complex include clivus chordoma? A case report. Eur J Pediatr 160:138","journal-title":"Eur J Pediatr"},{"key":"559_CR86","doi-asserted-by":"crossref","unstructured":"Kimmell KT, Dayoub H, Stolzenberg ED, Sincoff EH Chordoma in the lateral medullary cistern in a patient with tuberous sclerosis: a case report and review of the literature. Surg Neurol Int 1: 13. doi: 10.4103\/2152-7806.63908","DOI":"10.4103\/2152-7806.63908"},{"key":"559_CR87","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","volume":"18","author":"N Hay","year":"2004","unstructured":"Hay N, Sonenberg N (2004) Upstream and downstream of mTOR. Genes Dev 18:1926\u20131945. doi: 10.1101\/gad.1212704","journal-title":"Genes Dev"},{"key":"559_CR88","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1093\/annonc\/mdp210","volume":"20","author":"S Stacchiotti","year":"2009","unstructured":"Stacchiotti S, Marrari A, Tamborini E, Palassini E, Virdis E, Messina A, Crippa F, Morosi C, Gronchi A, Pilotti S, Casali PG (2009) Response to imatinib plus sirolimus in advanced chordoma. Ann Oncol 20:1886\u20131894. doi: 10.1093\/annonc\/mdp210","journal-title":"Ann Oncol"},{"key":"559_CR89","first-page":"1867","volume":"29","author":"J Schwab","year":"2009","unstructured":"Schwab J, Antonescu C, Boland P, Healey J, Rosenberg A, Nielsen P, Iafrate J, Delaney T, Yoon S, Choy E, Harmon D, Raskin K, Yang C, Mankin H, Springfield D, Hornicek F, Duan Z (2009) Combination of PI3\u00a0K\/mTOR inhibition demonstrates efficacy in human chordoma. Anticancer Res 29:1867\u20131871","journal-title":"Anticancer Res"},{"key":"559_CR90","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1158\/1535-7163.MCT-09-0504","volume":"8","author":"C Yang","year":"2009","unstructured":"Yang C, Schwab JH, Schoenfeld AJ, Hornicek FJ, Wood KB, Nielsen GP, Choy E, Mankin H, Duan Z (2009) A novel target for treatment of chordoma: signal transducers and activators of transcription 3. Mol Cancer Ther 8:2597\u20132605. doi: 10.1158\/1535-7163.MCT-09-0504","journal-title":"Mol Cancer Ther"},{"key":"559_CR91","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/BRS.0b013e3181b44387","volume":"35","author":"MU Jawad","year":"2010","unstructured":"Jawad MU, Scully SP (2010) Surgery significantly improves survival in patients with chordoma. Spine (Phila Pa 1976) 35:117\u2013123. doi: 10.1097\/BRS.0b013e3181b44387","journal-title":"Spine (Phila Pa 1976)"},{"key":"559_CR92","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1097\/BRS.0b013e3181bad11d","volume":"34","author":"JH Schwab","year":"2009","unstructured":"Schwab JH, Healey JH, Rose P, Casas-Ganem J, Boland PJ (2009) The surgical management of sacral chordomas. Spine (Phila Pa 1976) 34:2700\u20132704. doi: 10.1097\/BRS.0b013e3181bad11d","journal-title":"Spine (Phila Pa 1976)"},{"key":"559_CR93","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1097\/BRS.0b013e3181b61b90","volume":"34","author":"PC Hsieh","year":"2009","unstructured":"Hsieh PC, Xu R, Sciubba DM, McGirt MJ, Nelson C, Witham TF, Wolinksy JP, Gokaslan ZL (2009) Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients. Spine (Phila Pa 1976) 34:2233\u20132239. doi: 10.1097\/BRS.0b013e3181","journal-title":"Spine (Phila Pa 1976)"},{"key":"559_CR94","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1227\/01.NEU.0000215892.65663.54","volume":"58","author":"F Tzortzidis","year":"2006","unstructured":"Tzortzidis F, Elahi F, Wright DC, Temkin N, Natarajan SK, Sekhar LN (2006) Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chondrosarcomas. Neurosurgery 58:1090\u20131098. doi: 10.1227\/01.NEU.0000215892.65663.54 discussion 1090\u20131098","journal-title":"Neurosurgery"},{"key":"559_CR95","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/01.brs.0000200038.30869.27","volume":"31","author":"S Boriani","year":"2006","unstructured":"Boriani S, Bandiera S, Biagini R, Bacchini P, Boriani L, Cappuccio M, Chevalley F, Gasbarrini A, Picci P, Weinstein JN (2006) Chordoma of the mobile spine: fifty years of experience. Spine (Phila Pa 1976) 31:493\u2013503. doi: 10.1097\/01.brs.0000200038.30869.27","journal-title":"Spine (Phila Pa 1976)"},{"key":"559_CR96","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.ijrobp.2008.12.055","volume":"75","author":"C Ares","year":"2009","unstructured":"Ares C, Hug EB, Lomax AJ, Bolsi A, Timmermann B, Rutz HP, Schuller JC, Pedroni E, Goitein G (2009) Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report. Int J Radiat Oncol Biol Phys 75:1111\u20131118. doi: 10.1016\/j.ijrobp.2008.12.055","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"559_CR97","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1080\/02841860500326257","volume":"44","author":"G Noel","year":"2005","unstructured":"Noel G, Feuvret L, Calugaru V, Dhermain F, Mammar H, Haie-Meder C, Ponvert D, Hasboun D, Ferrand R, Nauraye C, Boisserie G, Beaudre A, Gaboriaud G, Mazal A, Habrand JL, Mazeron JJ (2005) Chordomas of the base of the skull and upper cervical spine. One hundred patients irradiated by a 3D conformal technique combining photon and proton beams. Acta Oncol 44:700\u2013708. doi: 10.1080\/02841860500326257","journal-title":"Acta Oncol"},{"key":"559_CR98","doi-asserted-by":"crossref","first-page":"A44","DOI":"10.1227\/01.NEU.0000341166.09107.47","volume":"64","author":"FC Henderson","year":"2009","unstructured":"Henderson FC, McCool K, Seigle J, Jean W, Harter W, Gagnon GJ (2009) Treatment of chordomas with CyberKnife: georgetown university experience and treatment recommendations. Neurosurgery 64:A44\u2013A53. doi: 10.1227\/01.NEU.0000341166.09107.47","journal-title":"Neurosurgery"},{"key":"559_CR99","doi-asserted-by":"crossref","unstructured":"Durante M, Loeffler JS (2010) Charged particles in radiation oncology. Nat Rev Clin Oncol 7:37\u201343. doi: 10.1038\/nrclinonc.2009.183","DOI":"10.1038\/nrclinonc.2009.183"},{"key":"559_CR100","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1097\/BRS.0b013e31815cde91","volume":"32","author":"E Ostroumov","year":"2007","unstructured":"Ostroumov E, Hunter CJ (2007) The role of extracellular factors in human metastatic chordoma cell growth in vitro. Spine (Phila Pa 1976) 32:2957\u20132964. doi: 10.1097\/BRS.0b013e31815cde91","journal-title":"Spine (Phila Pa 1976)"},{"key":"559_CR101","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijrobp.2006.12.059","volume":"68","author":"D Schulz-Ertner","year":"2007","unstructured":"Schulz-Ertner D, Karger CP, Feuerhake A, Nikoghosyan A, Combs SE, Jakel O, Edler L, Scholz M, Debus J (2007) Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. Int J Radiat Oncol Biol Phys 68:449\u2013457. doi: 10.1016\/j.ijrobp.2006.12.059","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"559_CR102","first-page":"1012","volume":"63","author":"P Sonveaux","year":"2003","unstructured":"Sonveaux P, Brouet A, Havaux X, Gregoire V, Dessy C, Balligand JL, Feron O (2003) Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy. Cancer Res 63:1012\u20131019","journal-title":"Cancer Res"},{"key":"559_CR103","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1200\/JCO.2005.02.170","volume":"23","author":"R Chugh","year":"2005","unstructured":"Chugh R, Dunn R, Zalupski MM, Biermann JS, Sondak VK, Mace JR, Leu KM, Chandler WF, Baker LH (2005) Phase II study of 9-nitro-camptothecin in patients with advanced chordoma or soft tissue sarcoma. J Clin Oncol 23:3597\u20133604. doi: 10.1200\/JCO.2005.02.170","journal-title":"J Clin Oncol"},{"key":"559_CR104","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/cncr.20618","volume":"101","author":"PG Casali","year":"2004","unstructured":"Casali PG, Messina A, Stacchiotti S, Tamborini E, Crippa F, Gronchi A, Orlandi R, Ripamonti C, Spreafico C, Bertieri R, Bertulli R, Colecchia M, Fumagalli E, Greco A, Grosso F, Olmi P, Pierotti MA, Pilotti S (2004) Imatinib mesylate in chordoma. Cancer 101:2086\u20132097. doi: 10.1002\/cncr.20618","journal-title":"Cancer"},{"key":"559_CR105","doi-asserted-by":"crossref","first-page":"10003","DOI":"10.1200\/jco.2007.25.18_suppl.10003","volume":"25","author":"StacchiottiS FV","year":"2007","unstructured":"FV StacchiottiS, Ferraresi G, Grignani F, Crippa A, Messina E, Tamborini CS, Gronchi A, Casali PG (2007) Imatinib mesylate in advanced chordoma: a multicenter phase II study. J Clin Oncol 25:10003","journal-title":"J Clin Oncol"},{"key":"559_CR106","first-page":"249","volume":"18","author":"F Orzan","year":"2007","unstructured":"Orzan F, Terreni MR, Longoni M, Boari N, Mortini P, Doglioni C, Riva P (2007) Expression study of the target receptor tyrosine kinase of Imatinib mesylate in skull base chordomas. Oncol Rep 18:249\u2013252","journal-title":"Oncol Rep"},{"key":"559_CR107","doi-asserted-by":"crossref","unstructured":"Ferraresi V, Nuzzo C, Zoccali C, Marandino F, Vidiri A, Salducca N, Zeuli M, Giannarelli D, Cognetti F, Biagini R (2010) Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients. BMC Cancer 10:22. doi: 10.1186\/1471-2407-10-22","DOI":"10.1186\/1471-2407-10-22"},{"key":"559_CR108","unstructured":"Casali PG, Stacchiotti S, Grosso F, Messina A, Crippa F, Tamborini E, Bertieri R, Collini P, Pilotti S, Gronchi A (2007) Adding cisplatin (CDDP) to imatinib (IM) re-establishes tumor response following secondary resistance to IM in advanced chordoma. 2007 ASCO Annual Meeting Proceedings Part I, Vol 25, No. 18S. J Clin Oncol(June 20 Suppl):10038"},{"key":"559_CR109","unstructured":"Stacchiotti S, Grosso F, Dileo P et al (2006) Antitumor activity of imatinib plus cisplatin in two patients with advanced chordoma. In: Proceedings of 12th Annual Connective Tissue Oncology Society Meeting 2006, 58 (Abstr 725)"},{"key":"559_CR110","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/1097-0142(19930801)72:3<714::AID-CNCR2820720314>3.0.CO;2-1","volume":"72","author":"GF Fleming","year":"1993","unstructured":"Fleming GF, Heimann PS, Stephens JK, Simon MA, Ferguson MK, Benjamin RS, Samuels BL (1993) Dedifferentiated chordoma. Response to aggressive chemotherapy in two cases. Cancer 72:714\u2013718","journal-title":"Cancer"},{"key":"559_CR111","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00043426-199605000-00032","volume":"18","author":"PG Scimeca","year":"1996","unstructured":"Scimeca PG, James-Herry AG, Black KS, Kahn E, Weinblatt ME (1996) Chemotherapeutic treatment of malignant chordoma in children. J Pediatr Hematol Oncol 18:237\u2013240","journal-title":"J Pediatr Hematol Oncol"},{"key":"559_CR112","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jso.2930370311","volume":"37","author":"A Azzarelli","year":"1988","unstructured":"Azzarelli A, Quagliuolo V, Cerasoli S, Zucali R, Bignami P, Mazzaferro V, Dossena G, Gennari L (1988) Chordoma: natural history and treatment results in 33 cases. J Surg Oncol 37:185\u2013191","journal-title":"J Surg Oncol"},{"key":"559_CR113","doi-asserted-by":"crossref","first-page":"E629","DOI":"10.1227\/01.NEU.0000350864.78326.14","volume":"65","author":"S Guiu","year":"2009","unstructured":"Guiu S, Guiu B, Feutray S, Chauffert B (2009) Direct intratumoral chemotherapy with carboplatin and epinephrine in a recurrent cervical chordoma: case report. Neurosurgery 65:E629\u2013E630. doi: 10.1227\/01.NEU.0000350864.78326.14 discussion E630","journal-title":"Neurosurgery"},{"key":"559_CR114","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/1871520611009010047","volume":"10","author":"C Parr","year":"2009","unstructured":"Parr C, Sanders AJ, Jiang WG (2009) Hepatocyte growth factor activation inhibitors\u2014therapeutic potential in cancer. Anticancer Agents Med Chem 10:47\u201357","journal-title":"Anticancer Agents Med Chem"},{"key":"559_CR115","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1158\/1078-0432.CCR-08-1306","volume":"15","author":"JP Eder","year":"2009","unstructured":"Eder JP, Vande Woude GF, Boerner SA, LoRusso PM (2009) Novel therapeutic inhibitors of the c-Met signaling pathway in cancer. Clin Cancer Res 15:2207\u20132214. doi: 10.1158\/1078-0432.CCR-08-1306","journal-title":"Clin Cancer Res"},{"key":"559_CR116","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3171\/jns.1991.75.3.0374","volume":"75","author":"ME Keisch","year":"1991","unstructured":"Keisch ME, Garcia DM, Shibuya RB (1991) Retrospective long-term follow-up analysis in 21 patients with chordomas of various sites treated at a single institution. J Neurosurg 75:374\u2013377. doi: 10.3171\/jns.1991.75.3.0374","journal-title":"J Neurosurg"},{"key":"559_CR117","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1097\/00007632-199607010-00017","volume":"21","author":"S Boriani","year":"1996","unstructured":"Boriani S, Chevalley F, Weinstein JN, Biagini R, Campanacci L, De Iure F, Piccill P (1996) Chordoma of the spine above the sacrum treatment and outcome in 21 cases. Spine (Phila Pa 1976) 21:1569\u20131577","journal-title":"Spine (Phila Pa 1976)"},{"key":"559_CR118","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3171\/jns.1997.86.2.0182","volume":"86","author":"O al-Mefty","year":"1997","unstructured":"al-Mefty O, Borba LA (1997) Skull base chordomas: a management challenge. J Neurosurg 86:182\u2013189. doi: 10.3171\/jns.1997.86.2.0182","journal-title":"J Neurosurg"},{"key":"559_CR119","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00006123-199901000-00041","volume":"44","author":"JE York","year":"1999","unstructured":"York JE, Kaczaraj A, Abi-Said D, Fuller GN, Skibber JM, Janjan NA, Gokaslan ZL (1999) Sacral chordoma: 40-year experience at a major cancer center. Neurosurgery 44:74\u201379 discussion 79\u201380","journal-title":"Neurosurgery"},{"key":"559_CR120","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/(SICI)1097-0142(20000501)88:9<2122::AID-CNCR19>3.0.CO;2-1","volume":"88","author":"P Bergh","year":"2000","unstructured":"Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W, Meis-Kindblom JM (2000) Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer 88:2122\u20132134. doi: 10.1002\/(SICI)1097-0142(20000501)88:9<2122:AID-CNCR19>3.0.CO;2-1","journal-title":"Cancer"},{"key":"559_CR121","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3171\/jns.2002.97.5.1070","volume":"97","author":"A Carpentier","year":"2002","unstructured":"Carpentier A, Polivka M, Blanquet A, Lot G, George B (2002) Suboccipital and cervical chordomas: the value of aggressive treatment at first presentation of the disease. J Neurosurg 97:1070\u20131077. doi: 10.3171\/jns.2002.97.5.1070","journal-title":"J Neurosurg"},{"key":"559_CR122","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.2106\/JBJS.D.02693","volume":"87","author":"B Fuchs","year":"2005","unstructured":"Fuchs B, Dickey ID, Yaszemski MJ, Inwards CY, Sim FH (2005) Operative management of sacral chordoma. J Bone Joint Surg Am 87:2211\u20132216. doi: 10.2106\/JBJS.D.02693","journal-title":"J Bone Joint Surg Am"},{"key":"559_CR123","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1227\/01.NEU.0000223441.51012.9D","volume":"59","author":"F Tzortzidis","year":"2006","unstructured":"Tzortzidis F, Elahi F, Wright D, Natarajan SK, Sekhar LN (2006) Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chordomas. Neurosurgery 59:230\u2013237. doi: 10.1227\/01.NEU.0000223441.51012.9D discussion 230\u2013237","journal-title":"Neurosurgery"},{"key":"559_CR124","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3171\/JNS-07\/08\/0319","volume":"107","author":"A Samii","year":"2007","unstructured":"Samii A, Gerganov VM, Herold C, Hayashi N, Naka T, Mirzayan MJ, Ostertag H, Samii M (2007) Chordomas of the skull base: surgical management and outcome. J Neurosurg 107:319\u2013324. doi: 10.3171\/JNS-07\/08\/0319","journal-title":"J Neurosurg"},{"key":"559_CR125","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00701-009-0383-5","volume":"151","author":"S Takahashi","year":"2009","unstructured":"Takahashi S, Kawase T, Yoshida K, Hasegawa A, Mizoe JE (2009) Skull base chordomas: efficacy of surgery followed by carbon ion radiotherapy. Acta Neurochir (Wien) 151:759\u2013769. doi: 10.1007\/s00701-009-0383-5","journal-title":"Acta Neurochir (Wien)"},{"key":"559_CR126","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11060-009-0068-1","volume":"98","author":"BJ Jian","year":"2010","unstructured":"Jian BJ, Bloch OG, Yang I, Han SJ, Aranda D, Tihan T, Parsa AT (2010) Adjuvant radiation therapy and chondroid chordoma subtype are associated with a lower tumor recurrence rate of cranial chordoma. J Neurooncol 98:101\u2013108. doi: 10.1007\/s11060-009-0068-1","journal-title":"J Neurooncol"},{"key":"559_CR127","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1227\/01.NEU.0000362000.35742.3D","volume":"66","author":"D Choi","year":"2010","unstructured":"Choi D, Melcher R, Harms J, Crockard A (2010) Outcome of 132 operations in 97 patients with chordomas of the craniocervical junction and upper cervical spine. Neurosurgery 66:59\u201365. doi: 10.1227\/01.NEU.0000362000.35742.3D discussion 65","journal-title":"Neurosurgery"},{"key":"559_CR128","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1245\/s10434-009-0740-x","volume":"17","author":"S Stacchiotti","year":"2010","unstructured":"Stacchiotti S, Casali PG, Lo Vullo S, Mariani L, Palassini E, Mercuri M, Alberghini M, Pilotti S, Zanella L, Gronchi A, Picci P (2010) Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers. Ann Surg Oncol 17:211\u2013219. doi: 10.1245\/s10434-009-0740-x","journal-title":"Ann Surg Oncol"},{"key":"559_CR129","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1007\/s11999-010-1472-8","volume":"468","author":"P Ruggieri","year":"2010","unstructured":"Ruggieri P, Angelini A, Ussia G, Montalti M, Mercuri M (2010) Surgical margins and local control in resection of sacral chordomas. Clin Orthop Relat Res 468:2939\u20132947. doi: 10.1007\/s11999-010-1472-8","journal-title":"Clin Orthop Relat Res"},{"key":"559_CR130","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10143-010-0273-6","volume":"33","author":"Z Wu","year":"2010","unstructured":"Wu Z, Zhang J, Zhang L, Jia G, Tang J, Wang L, Wang Z (2010) Prognostic factors for long-term outcome of patients with surgical resection of skull base chordomas-106 cases review in one institution. Neurosurg Rev 33:451\u2013456. doi: 10.1007\/s10143-010-0273-6","journal-title":"Neurosurg Rev"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-011-0559-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-011-0559-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-011-0559-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T01:38:02Z","timestamp":1712281082000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-011-0559-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,8]]},"references-count":130,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["559"],"URL":"https:\/\/doi.org\/10.1007\/s11060-011-0559-8","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,8]]}}}